Antibacterial agent 364
Antibacterial agent 364 is an antibacterial agent. Antibacterial agent 364 inhibits the expression of the hrpY gene and downregulates the expression of prhG, phcA, prhA and prhR. Antibacterial agent 364 impairs the swimming motility of Ralstonia solanacearum, suppresses the T3SS-related regulatory network, and attenuates the virulence of Ralstonia solanacearum without inhibiting bacterial growth. Antibacterial agent 364 is applicable to studies related to plant infections.
For research use only. We do not sell to patients.
- CAS No.: 2293958-34-4
- Formula: C17H15ClN2O2S
- Molecular Weight:346.83
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
Antibacterial agent 364 (compound W40) (100 μM; 8 h) potently inhibits transcription driven by the hrpY promoter in Ralstonia solanacearum GMI1000, with an inhibition rate of 96.45%, without affecting bacterial growth[1].
Antibacterial agent 364 (100 μM) inhibits the expression of prhG, prhA, prhR, phcA and ripW genes in Ralstonia solanacearum GMI1000, but does not alter the expression of other tested T3SS regulatory genes, virulence-related genes and effector protein genes[1].
Antibacterial agent 364 (100 μM; 72 h) impairs the swimming motility of Ralstonia solanacearum GMI1000 following incubation on semi-solid assay plates[1].
Antibacterial agent 364 (100 μM) has no effect on biofilm formation, extracellular polysaccharide production, or cellulase activity of Ralstonia solanacearum GMI1000[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 2293958-34-4
-
Molecular Weight 346.83
-
Formula C17H15ClN2O2S
-
SMILES
CC1=CC=C(C=C1)CSC2=NN=C(C(C3=CC=C(Cl)C=C3)O)O2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Aerobic Bacterial Batch Culture on Broth/Agar
Aerobic bacterial batch culture grows a closed inoculated population in broth or on agar without continuous medium replacement; growth readouts include turbidity/OD for total suspended biomass and colony-forming units for viable cells able to form colonies on agar. OD-based growth curves reflect light scattering by cells, but OD is instrument-, pathlength-, species-, cell-size-, and density-dependent, so OD should be calibrated or interpreted alongside viable counts when quantitative cell density is required.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)